Weil Pharmaceutical announced that the company previously reviewed and approved the repurchase plan. It plans to use no less than RMB 50 million and no more than RMB 100 million to repurchase shares for employee stock ownership plans or equity incentives. The repurchase price will not exceed 40.11 yuan/share. On October 14, 2026, the company repurchased 53,000 shares for the first time, accounting for 0.04% of the total share capital. The transaction price was 26.13 yuan/share to 26.47 yuan/share, and the payment was RMB 1.3932 million.

Zhitongcaijing · 2d ago
Weil Pharmaceutical announced that the company previously reviewed and approved the repurchase plan. It plans to use no less than RMB 50 million and no more than RMB 100 million to repurchase shares for employee stock ownership plans or equity incentives. The repurchase price will not exceed 40.11 yuan/share. On October 14, 2026, the company repurchased 53,000 shares for the first time, accounting for 0.04% of the total share capital. The transaction price was 26.13 yuan/share to 26.47 yuan/share, and the payment was RMB 1.3932 million.